跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18,130 条关于
“CRISM Therapeutics Corporation”
全部
18,130
临床试验
3,824
药物
3,206
机构
1,579
资讯
9,521
2个月前
CRISM Therapeutics Advances Toward Patient Recruitment for Phase II Glioblastoma Trial of Irinotecan ChemoSeed
去年
CRISM Therapeutics Partners with Aixial Group to Advance ChemoSeed Glioblastoma Trial
6个月前
CRISM Therapeutics Secures FDA Orphan Drug Designation for Brain Cancer Treatment
去年
CRISM Therapeutics Advances Toward Phase 2 Glioblastoma Trial Despite Widening Losses
11个月前
CRISM's ChemoSeed Platform Shows 72% Cancer Cell Kill Rate in Prostate Cancer Preclinical Studies
去年
Geron Corporation Advances in Myeloid Hematologic Malignancies Treatment
去年
Journey Medical's Emrosi Receives FDA Approval for Rosacea Treatment
去年
PDS Biotech Updates Phase 3 VERSATILE-003 Trial Design for HPV16-Positive HNSCC
去年
Genelux Advances Olvi-Vec Trials in Lung and Ovarian Cancer, Anticipates Key Data Readouts
3年前
Geron's Imetelstat Shows Promise in MDS and Myelofibrosis Trials, NDA Submission on Track
第 1 页，共 953 页
上一页
下一页
